Has R&D productivity increased since last year’s analysis? Who are the new entrants into the elite top five group, and who has dropped out? Have the positive innovation dynamics of recent years continued? (Also see "Value-Based R&D Pharma Productivity 2015: Oncology And Hep C Drive Top Performers" - In Vivo, 18 December, 2015.)
Our annual survey suggests that the fundamental innovation performance of our sample of top 30 companies has improved considerably since we published the first survey in 2014. (Also see "
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?